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Here, we introduce an engineered, tunable
genetic switch that couples repressor proteins
and an RNAi target design to effectively turn
any gene off. We used the switch to regulate
the expression of EGFP in mouse and human
cells and found that it offers >99% repression
as well as the ability to tune gene expression.
To demonstrate the system’s modularity and
level of gene silencing, we used the switch to
tightly regulate the expression of diphtheria
toxin and Cre recombinase, respectively. We
also used the switch to tune the expression of
a proapoptotic gene and show that a threshold
expression level is required to induce apopto-
sis. This work establishes a system for tight,
tunable control of mammalian gene expression
that can be used to explore the functional role of
various genes as well as to determine whether
a phenotype is the result of a threshold
response to changes in gene expression.
INTRODUCTION
Synthetic biology is an emerging field that aspires to
design and build functioning biological circuits, including
gene expression systems, using well-characterized bio-
molecular components and genetic modules (Atkinson
et al., 2003; Basu et al., 2004; Becskei and Serrano,
2000; Blake et al., 2003; Elowitz and Leibler, 2000; Elowitz
et al., 2002; Fung et al., 2005; Gardner et al., 2000; Guet
et al., 2002; Guido et al., 2006; Hooshangi et al., 2005;
Isaacs et al., 2003, 2004; Isalan et al., 2005; Kobayashi
et al., 2004; Kramer et al., 2004, 2005; Kramer and Fusse-
negger, 2005; Malphettes and Fussenegger, 2006; Ozbu-
dak et al., 2002; Pedraza and van Oudenaarden, 2005;
Rosenfeld et al., 2002, 2005; You et al., 2004). Generating
high-fidelity and inducible gene expression systems that
can operate in an intact organismwould assist experimen-
tal studies of cellular function, development, and disease.Several techniques exist to regulate gene expression;
however, each carries its own caveat in function. It was
discovered that both the tetR and lacI Escherichia coli
repressor systems function in mammalian cell tissue
culture and in mice (Brown et al., 1987; Gossen and
Bujard, 1992; Hu and Davidson, 1987; Scrable, 2002),
which proved to be a great advance in the understanding
of cellular function. Other similar techniques have been
used, including the inducible Gal4/UAS system, to control
gene expression at the transcriptional level (Ornitz et al.,
1991). While these techniques offer good repression,
they exhibit leakiness that precludes the gene of interest
from being completely turned off. Studies performed
with double-stranded RNA in the nematode Caenorhabdi-
tis elegans revealed a sequence-specific RNA-mediated
pathway for turning off gene expression (Fire et al.,
1998; Guo and Kemphues, 1995). This process, known
as RNA interference (RNAi), has been adapted for use in
tissue culture and mammals with the introduction of small
interfering RNAs (siRNAs) and short-hairpin RNAs
(shRNAs). RNAi has revolutionized biological research;
however, targeting locations on mRNAs for robust knock-
down is empirical and often requires screening very large
numbers of selected mRNA sequences (Paddison et al.,
2004). Additionally, off-target effects can affect genes
not related to the gene of interest. A commonly used
method to activate or inactivate gene expression in mice
involves the use of site-specific cre recombinase (cre).
cre, which was derived from bacteriophage P1, mediates
the deletion of a DNA sequence flanked by a pair of cre
recognition sequences, called loxP sites (Sternberg and
Hamilton, 1981). A disadvantage of this approach is that
it is dependent on the coexpression of the transgene
cre, which causes a permanent genetic event, restricting
any regulation of gene expression. This approach can be
made inducible with the application of cre-ERTM or
ERT2 fusion proteins; however, the inducing ligand,
tamoxifen, can be toxic at the dosage levels required for
recombination (Danielian et al., 1998; Imai et al., 2001).
The caveats associated with these systems for regulating
gene expression make it difficult to study many funda-
mental questions concerning cellular processes and
diseases.Cell 130, 363–372, July 27, 2007 ª2007 Elsevier Inc. 363
Figure 1. Schematic Diagrams of the
Synthetic Gene Network
(A) In the uninduced state (LTRi-EGFP in the off
state), LacI repressor proteins are constitu-
tively expressed (blue) and bind to the lac oper-
ator sites in the transgene module (green). This
causes transcriptional repression of EGFP. The
LacI repressor proteins also bind to the lac
operator sites in the tetR repressor module
(yellow), which causes transcriptional repres-
sion of TetR. With the repression of TetR,
shRNA is transcribed by the U6 promoter and
complementarily binds to the synthetic target
sequence located in the 30UTR of the EGFP
mRNA. Any EGFP leakage of the transcript is
targeted by the RNAi module (pink), resulting
in undetectable EGFP expression.
(B) In the induced state (LTRi-EGFP in the on state), isopropyl-b-thiogalactopyranoside (IPTG) binds to the LacI proteins, producing a conformational
change in the repressor proteins. This causes them to no longer bind to the lac operator sites, which allows for the transcription of EGFP and tetR. The
Tet repressor proteins bind to the tet operator site located in the U6 promoter of the RNAi module, repressing the transcription of the shRNA. The
resulting effect is robust expression of EGFP.To address this problem, we have developed within the
context of synthetic biology a tunable mammalian genetic
switch. We engineered the switch by creating a synthetic
gene network that couples repressor proteins with an
RNAi design involving shRNA; we call this switch LTRi,
which stands for Lac-Tet-RNAi. Gene expression is turned
on by adding an inducer, isopropyl-b-thiogalactopyrano-
side (IPTG), which controls the repressor elements at the
transcriptional level, while simultaneously turning off the
RNAi component to allow the transcript to be retained
and translated. The switch is modular in nature, allowing
for the regulation of any gene.
We used the genetic switch to regulate EGFP (LTRi-
EGFP) in chinese hamster ovary (CHO) cells and human
embryonic kidney 293 (HEK293) cells and found that it
offers >99% repression compared to positive controls.
In addition to sustaining a tight off state, LTRi also exhibits
tunable, reversible control of gene expression. We used
LTRi to control the expression of the highly toxic a chain
of diphtheria toxin, DTA (LTRi-DTA), in order to demon-
strate the system’s modularity and level of gene silencing.
We found that cells with LTRi-DTA in the off state survive
despite the presence of the DTA gene and can be trig-
gered to die following induction with IPTG. To demon-
strate the potential for other in vivo experimental applica-
tions, we used the switch to control the expression of Cre
recombinase (LTRi-cre) in Rosa26 primary mouse cells.
Similar to the LTRi-DTA results, we found that cells with
LTRi-cre in the off state exhibit no expression of the cre
transgene, and genetic recombination is observed only
following induction of the switch with IPTG. To explore
whether LTRi is capable of regulating a biological process,
we put bax, a proapoptotic gene, under its control (LTRi-
bax). Bax is a member of the Bcl-2 family of proteins
that has been associated with apoptotic death both in
cell culture and in intact animals (Aneja et al., 2006;
Pastorino et al., 1998; Shinoura et al., 1999). The overex-
pression of Bax has been shown to cause apoptosis by364 Cell 130, 363–372, July 27, 2007 ª2007 Elsevier Inc.disrupting the mitochondrial transmembrane potential
and releasing cytochrome c from the mitochondria
(Katiyar et al., 2005; van Engeland et al., 1998). By tuning
the level of Bax in primary mouse cells, we show that
a threshold level of Bax is required to induce apoptosis.
This work establishes a system for tight, tunable, revers-
ible control of mammalian gene expression that can be
used to explore the functional role of developmental
genes and mechanisms of biological switches, as well
as to assay threshold responses to changes in gene
expression.
RESULTS
Design of the Genetic Switch
We initially used our genetic switch to regulate the expres-
sion of enhanced green fluorescent protein, EGFP (LTRi-
EGFP). LTRi-EGFP was designed so that in the off state
(Figure 1A), LacI provides transcriptional repression of
EGFP and any leakage of the EGFP transcript is knocked
down by the RNAi component of the switch. Specifically,
the lacI repressor module produces LacI proteins that
bind to the lac operator sites located in an intron adjacent
to EGFP in the transgenemodule. Any EGFPmRNA that is
transcribed as a result of incomplete repression is subse-
quently targeted for degradation by shRNA produced by
the RNAi module. The shRNA molecules target the
mRNA of EGFP via a synthetic target sequence that was
placed in the 30UTR. In addition to repressing the tran-
scription of the transgene, the LacI proteins also repress
the second repressor module in the system, the tetR
repressor module. This component controls the function-
ality of the RNAi module by regulating the transcription of
shRNA molecules that target the mRNA of EGFP. The
genetic switch can be flipped to the on state (Figure 1B)
by adding IPTG, which binds to LacI and produces a con-
formational change in the repressor proteins, causing
them to no longer bind to the lac operator sites. This allows
Figure 2. Building and Testing the Genetic Switch in a Modular Fashion
In (A)–(D), the first column includes a schematic diagram of the tested module, while the second and third columns include fluorescence and bright-
field microscope images, respectively, of cells containing the tested module.
(A) The transgene module served as our positive control (corresponding to maximum EGFP expression).
(B) The RNAi module was added to the transgene module to characterize its functionality. Microscope images show that RNAi alone is incapable of
suppressing EGFP expression to undetectable levels.
(C) The lacI repressor module was added to the transgene module to characterize its functionality. Microscope images show that transcriptional
repression alone is incapable of suppressing EGFP expression to undetectable levels.
(D) The lacI repressor and RNAi modules were added together to the transgene module to characterize their combined functionality. Microscope
images show that there is effectively no EGFP expression when the transcriptional and posttranscriptional mechanisms are coupled together.
(E) To quantify the expression of EGFP, we repeated the experiments described in (A)–(D) using flow cytometry. All EGFP expression levels were
normalized to the maximum EGFP expression level. Each bar represents the mean EGFP expression in eight independent experiments. In this
and all other figures, error bars represent standard deviations.for the transcription of EGFP and tetR. The Tet repressor
proteins bind to the tet operator site located in the U6
promoter of the RNAi module, which represses the tran-
scription of shRNA. The resulting effect is robust expres-
sion of EGFP.Construction and Functional Characterization
of the Genetic Switch
We constructed LTRi-EGFP in a modular fashion and
tested it using microscopy and flow cytometry (Fig-
ure 2). First, we designed a posttranscriptional moduleCell 130, 363–372, July 27, 2007 ª2007 Elsevier Inc. 365
that uses a U6 promoter containing a tet operator site
to transcribe a 42 nucleotide RNA transcript. This tran-
script forms a shRNA and has complementarity to a 19
nucleotide sequence in the E. coli b-galactosidase
sequence. This 19 nucleotide target sequence was
placed in the 30UTR of the EGFP gene to be targeted
by the shRNA, giving rise to a system that is not
gene specific, allowing for any transgene to be con-
trolled by the module. Furthermore, by designing the
target sequence to have complementarity to b-galacto-
sidase, we minimized any potential off-target effects
that could be caused by the RNAi module. Using tran-
sient transfections, we compared the expression of
EGFP with and without the target and found that the
presence of the target sequence in the 30UTR did not
significantly change the expression of EGFP. As a
result, we used the transgene module controlling the
expression of EGFP with the target sequence
(Figure 2A) as our positive control (corresponding to
maximum EGFP expression).
Next, we placed the RNAi module on the same plas-
mid as the transgene module to test the effectiveness
of RNAi alone (Figure 2B). Using transient transfections,
we found that this system offers approximately 80%
knockdown of the transgene (Figure 2E) compared to
the positive control. Microscope images confirmed that
RNAi alone is incapable of completely shutting off
EGFP expression (Figure 2B). We tested other target se-
quences (e.g., to luciferase) and obtained similar results.
To ensure that the shRNA effect was due to targeting
the 30UTR sequence, we placed the RNAi module onto
a plasmid that expressed EGFP but lacked the target
sequence in the 30UTR. Importantly, we observed no
change in the expression of EGFP, indicating that the
shRNA did not exhibit off-target effects with respect to
EGFP.
We then placed the lacI repressor module on the same
plasmid as the transgene module to examine the effec-
tiveness of repression alone (Figure 2C). Using transient
transfections, we found that this system offers approxi-
mately 85% repression (Figure 2E) compared to the pos-
itive control. Similar to the RNAi module, microscope
images showed that transcriptional repression alone is
incapable of completely shutting off EGFP expression
(Figure 2C).
Finally, we coupled the transcriptional and posttran-
scriptional mechanisms by placing both the lacI repressor
module and the RNAi module on the same plasmid as the
transgene module (Figure 2D). We found that this system
offers greater than 99% repression (Figure 2E) compared
to the positive control. Microscope images confirmed
that there is effectively no EGFP expression when the
transcriptional and posttranscriptional mechanisms are
coupled together (Figure 2D). To complete our synthetic
gene network, we added the last module, the tetR repres-
sor module (Figure 1). As noted above, this module acts to
repress the transcription of the shRNA molecules from
the RNAi module.366 Cell 130, 363–372, July 27, 2007 ª2007 Elsevier Inc.Characterizing the Dynamics and Tunability
of the Genetic Switch
Next, we stably transfected LTRi-EGFP into CHO cells to
characterize the dynamics of the system. Using flow
cytometry, we studied the switching-time characteristics
of the network over a 14 day period (Figure 3A, solid blue
line). After 3 days of induction, the system was fully in-
duced, exhibiting expression levels approximately 85-
fold greater than basal levels. When the inducer was
removed, full repression/knockdown was observed in
3 days. The system could be repeatedly and reversibly
induced on and off with the addition and removal of
IPTG (Figure 3A). To validate the levels of EGFP protein
expression, immunoblots were performed on the speci-
fied days of induction (see Figure S1A in the Supplemen-
tal Data available with this article online). Consistent with
our flow cytometry results, the immunoblots showed no
detectable EGFP protein in the absence of inducer and
a gradual increase in EGFP protein up until day 3 of in-
duction. Our flow cytometry data (Figure S1B) also
showed that the induction of the switch was uniform
across the cells, i.e., an induction level of 50% arose
from all cells expressing at approximately 50% of the
maximum.
We also added different amounts of IPTG and showed
that our switch can be used to tune the level of EGFP
expression (Figure 3B). We found that EGFP expression
can be maintained at different levels by varying inducer
concentrations. To further examine the flexibility and con-
trol maintained by LTRi, we chose three induction levels:
high (1 mM IPTG), medium (25 mM IPTG), and low
(250 pM IPTG). After full induction at each of these levels,
the expression of EGFP was turned off (Figure 3C). The
cells originally at the high induction level (1 mM IPTG)
were reinduced with 250 pM IPTG, and the cells originally
at the low induction level (250 pM IPTG) were reinduced
with 1 mM IPTG. The cells originally at the medium induc-
tion level (25 mM IPTG) were reinduced at the same level.
We found that we could predictably manipulate the
expression of EGFP by changing the amount of inducer,
independent of the expression history of the switch
(Figure 3C). Together, these results show that LTRi can
precisely control the expression level of individual genes
in a tunable and reversible fashion.
To compare the dynamics of our switch in other cell
lines, we stably transfected LTRi-EGFP into HEK293 cells.
Our results indicate that the dynamics of LTRi is indepen-
dent of cell type (Figure 3A). Moreover, we investigated
dose-response levels of LTRi-EGFP in both CHO and
HEK cells by examining different induction levels at day
3 of induction and obtained similar dose-response char-
acteristics (Figure 3D). Likewise, we found that LTRi can
be used to tune the expression of EGFP in HEK293 cells
with results similar to those obtained in CHO cells
(Figure S2). Together, these results show that our system
can precisely control the expression level of an individual
gene in a tunable and reversible fashion, regardless of cell
type.
Figure 3. The Genetic Switch Controls Gene Expression in a Tunable and Reversible Fashion
(A) CHO cells (solid blue line with circles) and HEK293 cells (dotted red line with triangles) were stably transfected with LTRi-EGFP. Using flow
cytometry, we studied the switching time over a 14 day period. The system was repeatedly induced on and off. Each data point represents the
average EGFP expression in at least five independent experiments.
(B) The tunability of LTRi-EGFP stably transfected in CHO cells was studied by adding five different amounts of inducer. Each data point represents
the average EGFP expression in at least five independent experiments.
(C) To examine the flexibility of the control maintained by the switch stably transfected in CHO cells, three different induction levels were chosen: high
(1 mM IPTG), medium (25 mM IPTG), and low (250 pM IPTG). After full induction at each of these levels, the expression of EGFP was turned off. The
cells originally at the high induction level (blue data points) were reinduced at the low level, and the cells originally at the low induction level (red data
points) were reinduced at the high level. The cells originally at the medium induction level (black data points) were reinduced at the same level. Each
data point represents the average EGFP expression in at least five independent experiments.
(D) An induction curve is shown for both stably transfected CHO cells (solid blue line with circles) and HEK293 cells (dotted red line with triangles).
Each data point represents the mean EGFP expression in ten independent experiments.Demonstrating the Tight Repression and Biological
Utility of the Genetic Switch
Because the regulatory elements of LTRi that are respon-
sible for the tight control of gene expression are not
associatedwith either a specific transgene or specific pro-
moters, the switch is capable of controlling any gene of
interest. In addition, tissue-specific promoters can be
used for in vivo experiments. To emphasize this modular-
ity and to highlight the level of gene silencing achieved by
the switch, we replaced EGFP with DTA (LTRi-DTA)
(Figure 4A). DTA functions by inhibiting protein synthesis
(Greenfield et al., 1983), and it has been shown to be highly
toxic in cells, with a single molecule being sufficient to kill
a cell (Yamaizumi et al., 1978). Despite DTA’s toxicity, we
were able to establish stable cell lines containing theswitch controlling the expression of DTA and to grow
them for more than 4 weeks. To confirm that all cells in
culture contained LTRi-DTA, we added EGFP driven by
a constitutive promoter to the same plasmid as the genetic
switch (Figure 4A). Thus, any cell expressing EGFP also
carried the switch regulating the expression of DTA.
Impressively, we found that cells with the genetic switch
in the off state survived despite the presence of the DTA
gene (Figure 4B) and could be triggered to die following
induction with IPTG (Figure 4C). Microscope images con-
firmed these findings (Figures 4B and 4C), which clearly
demonstrated that our engineered switch can be used to
effectively turn any gene off.
To explore other potential in vivo experimental applica-
tions, we used LTRi to regulate the expression of CreCell 130, 363–372, July 27, 2007 ª2007 Elsevier Inc. 367
Figure 4. The Genetic Switch Tightly Controls DTA Expression
(A) Schematic diagram of LTRi-DTA.
(B) The first column shows a schematic diagram of LTRi-DTA in the off state, along with an EGFP reporter module. The second and third columns
show bright-field and fluorescence microscope images, respectively, of cells with LTRi-DTA in the off state.
(C) The first column shows a schematic diagram of LTRi-DTA in the on state, along with an EGFP reporter module. The second and third columns
show bright-field and fluorescence microscope images, respectively, of cells with LTRi-DTA in the on state.recombinase (Figure 5A). LTRi-cre was transiently trans-
fected into primary mouse fibroblasts derived from
Rosa26 b-galactosidase reporter cells (Soriano, 1999). In
these cells, Cre recombinase activity results in the dele-
tion of transcriptional stop elements and facilitates the
expression of b-galactosidase (Figure S3). In this context,
genetic recombination occurs, causing a permanent
genetic modification, so even low levels of Cre expression
can be detected histologically. In this experiment, the syn-
thetic target in the transgene module was changed to a 19
nucleotide segment of luciferase. Cells with LTRi-cre in
the off state showed no indication of b-galactosidase
activity (Figure 5B). However, upon induction of the switch
with IPTG, cells that were transfected with LTRi-cre
expressed the b-galactosidase protein and turned blue
(Figure 5C).
To investigate whether LTRi can also be used to regu-
late a biological process, we put bax, a proapoptotic
gene, under the control of the switch (LTRi-bax)
(Figure 6A). As previously reported, the overexpression
of Bax causes cells to undergo apoptosis, and high levels
of Bax protein are widely regarded as a hallmark of cells
undergoing apoptosis (Pastorino et al., 1998; Shinoura
et al., 1999; Wolter et al., 1997). pUC19 was transfected
into Rosa26 cells to establish a basal level of apoptosis
and cell death that results from transfecting the cells. All
data were normalized to the level of dye retention obtained
from these transfections. Transient transfections of LTRi-
bax were performed and analyzed 48 hr after transfection
at four different induction levels: 0, 250 pM, 2.5 mM, and
1 mM IPTG. We found that at low and moderate levels of
Bax expression, cells did not display increased levels of368 Cell 130, 363–372, July 27, 2007 ª2007 Elsevier Inc.apoptosis (Figure 6B); however, at high levels of Bax
expression, there was a significant increase in apoptosis
and cell death (Figure 6B). These findings indicate a possi-
ble threshold response for Bax-induced apoptosis. To
ensure that cell death and apoptosis were not a result of
the presence of IPTG, we exposed nontransfected cells
to the indicated levels of IPTG and found no change in
apoptosis or cell death (Figure 6B).
DISCUSSION
Despite sophisticated advances in developing tools for
controlling gene expression, the ability to effectively regu-
late a transgene of interest is still imperfect due to leaki-
ness, poor induction levels, and irreversibility of the
genetic modification. In this study, we show that these
limitations can be overcome by engineering a genetic
network of interacting modules for regulating mammalian
gene expression. We use well-characterized, individually
engineered modules to create a genetic circuit that
exhibits undetectable levels of gene expression in the off
state. Gene expression is triggered by the addition of
IPTG, and the level of transgene expression can be pre-
cisely and reversibly tuned by adding various amounts
of IPTG. Impressively, as seen with the stable cell lines
containing the switch controlling EGFP and DTA, a regu-
lated state can be transmitted as cells grow and divide.
Recently, Szulc et al. (2006) introduced a method for
controlling both Pol II- and Pol III-type promoters using
the KRAB domain tethered to the tetR repressor. This sys-
tem was used to regulate the production of a transgene
and shRNA to a separate target gene in the cellular
Figure 5. The Genetic Switch Tightly
Controls Cre Expression
(A) Schematic diagram of LTRi-cre. Rosa26
cells were transiently transfected with LTRi-
cre.
(B) The first column shows a schematic
diagram of LTRi-cre in the off state. The sec-
ond column shows a bright-field microscope
image of cells with LTRi-cre in the off state.
(C) The first column shows a schematic dia-
gram of LTRi-cre in the on state. The second
column shows a bright-field microscope image
of cells with LTRi-cre in the on state.genome.While thismethod offers an approach for regulat-
ing endogenous genes, it lacks specificity and robustness
because the shRNAs target mRNA sequences of the
endogenous gene of interest; this could lead, in many
cases, to undesirable off-target effects.
More recently, Banaszynski et al. (2006) generated
a technique for regulating protein stability in mammalian
cells by fusing a 107 amino acid residue from the rapamy-
cin-binding protein (FKBP) to a protein of interest. They
showed that the residue can function as a destabilizing
domain (DD) to render the protein fused to this domain
unstable and thus no longer functional. The addition of a
ligand protects the protein fused to the DD from degrada-
tion; therefore, the protein becomes functional with the
addition of the ligand (Banaszynski et al., 2006). This
system offers an approach for regulating gene expressionthrough a posttranslational mechanism. However, the
requirement for fusion proteins is potentially an important
limitation for studying native protein function. Fusion pro-
teins often do not function like native proteins since the
introduction of the additional amino acids disrupts folding,
which can sterically inhibit catalytic or protein binding
domains.
It is well-established that dynamic changes of gene
expression levels occur throughout the life of organisms,
particularly during development and the onset of disease
or pathology. The tunability of LTRi makes it an ideal tool
for studying the mechanisms involved in cellular pro-
cesses and diseases. Currently, many genetic pheno-
types are mimicked in mouse models by generating
knockout animals. While this process can offer many
insights based on the phenotype of an animal missingFigure 6. The Genetic Switch Tunes the
Expression Level of Bax, Revealing
a Possible Threshold Effect for Inducing
Apoptosis
(A) Schematic diagram of LTRi-bax. Rosa26
cells were transiently transfected with LTRi-
bax.
(B) Quantitative flow cytometry analysis of
apoptotic and dead cells using annexin V and
propidium iodide (PI) staining. After 48 hr of
induction at the indicated IPTG levels, cells
were stained and analyzed using Alexa Fluor
488-conjugated annexin V along with PI. The
apoptotic cells were Alexa Fluor 488 positive
and PI negative, whereas the dead cells were
PI positive. Low and moderate levels of Bax
show no increase in either apoptosis or cell
death, whereas high induction levels of Bax
indicate a significant increase in apoptosis
and cell death. To ensure that cell death and
apoptosis did not result from the presence of
IPTG, we exposed nontransfected cells to the
indicated levels of IPTG (black lines). Each
data point represents the mean expression of
annexin V and PI in four independent
experiments.Cell 130, 363–372, July 27, 2007 ª2007 Elsevier Inc. 369
a particular gene, it only allows for the comparison of two
extreme cases of gene expression, on versus off. Because
our switch exhibits undetectable expression levels of the
transgene in the off state and has the ability to tune the ex-
pression of the transgene, it will allow the design of exper-
iments to study phenotypes based on threshold re-
sponses of gene expression both in vitro and in vivo.
Along these lines, we used LTRi to control the expression
of bax, a proapoptotic gene, in primary mouse cells and
found a possible threshold response for Bax-induced ap-
optosis.
Using LTRi to regulate the expression of Cre in trans-
genic mice would give rise to an in vivo, nontoxic inducible
knockout system that allows for controlling the timing of
the specific gene to be knocked out. This will make it pos-
sible to study genes that would otherwise be lethal if
removed too early in the development of the mouse. We
have established the feasibility of this application by
showing that LTRi can be used to tightly regulate the
expression of Cre recombinase in primary mouse fibro-
blasts. Additionally, using LTRi to regulate DTA could be
of significant value for a variety of mechanistic studies—
e.g., neurodegenerative diseases could be studied by
using a tissue-specific promoter to destroy a single type
of neuron in mice. The ability to control the expression of
DTA with LTRi could also be used for targeting cancer
cells (Anderson et al., 2004; Peng et al., 2002). Overall,
this work establishes a system for tight, tunable, reversible
control of mammalian gene expression that can be used
to explore a number of biological processes (e.g., stem
cell differentiation) and the functional role of various genes
(e.g., those involved in development or the onset of
disease).
EXPERIMENTAL PROCEDURES
Synthetic Network Construction
The CMV, RSV, and U6 promoters were amplified by PCR from
pCMVLacI (Stratagene), pOPI3CAT (Stratagene), and U6/tetO (a gift
from D. Takai, University of Tokyo), respectively. The SV40 introns
containing three lac operator siteswere PCR amplified frompOPI3CAT
(Stratagene). Genes encoding EGFP, TetR, and LacI were amplified by
PCR from pIRES2-EGFP (Clontech), pcDNA6/TR (Invitrogen), and
pCMVLacI (Stratagene), respectively. The genes encoding DTA and
neomycin resistance were cut out of p22EDT1 (a gift from J. Sawicki,
Lankenau Institute for Medical Research) and pNHS103_v3 (a gift
from M. Deans, Harvard Medical School) plasmids, respectively. The
bax gene was PCR amplified from pcDNA3-bax (Addgene) and
inserted into LTRi.
Cell Culture Conditions and Transfections
CHO-K1 and HEK293 cells were obtained from ATCC (ATCC CCL61
and CRL1573, respectively). The CHO-K1 cells were maintained in
F12K medium containing 10% FBS and penicillin/streptomycin, and
the HEK293 cells were maintained in DMEM medium containing
10% FBS and penicillin/streptomycin. Both cells lines were grown in
a humidified 5% CO2, 37
C incubator. The day before transfection,
cells were plated in a 12-well plate to 85% confluency. These cells
were transfected with 1.6 mg of expression plasmid using Lipofect-
amine 2000 reagent (Invitrogen). For the transient experiments, cells370 Cell 130, 363–372, July 27, 2007 ª2007 Elsevier Inc.were washed with PBS, trypsinized, and analyzed by flow cytometry
24 hr after transfection.
Rosa26fibroblastswereobtained fromembryonicday14.5Rosa26-R
mice. The cells weremaintained in embryonic fibroblast medium (high-
glucose DMEM, 10% FBS, penicillin/streptomycin, L-glutamine, and
sodium pyruvate) and grown in a humidified 5% CO2, 37
C incubator.
Thesecellswere transfectedwith 0.8mgof LTRi-creandLTRi-baxusing
Lipofectamine 2000 reagent (Invitrogen). The LTRi-cre cells were ana-
lyzed by b-galactosidase staining 48 hr after transfection. The LTRi-bax
cells were stained and analyzed by flow cytometry 48 hr after transfec-
tion.
For establishing stable cell lines, cells were plated in a 10 cm dish at
85% confluency the day before transfection. The expression vector
was linearized, and cells were transfected with the linearized vector
using Lipofectamine 2000 per the manufacturer’s protocol. Twenty-
four hours after transfection, cells were passed and cultured in the
presence of the antibiotic G418 (600 mg/ml, Invitrogen) for 2 weeks.
The neomycin resistance (neo) gene encoded on the vector confers
resistance to G418 and is an indication of stable integration of plasmid
DNA into the host cell chromosomes. Stable colonies were picked and
grown in separate dishes for analysis using flow cytometry.
Inducing Cells with IPTG
For the transient experiments, 1 mM of IPTG was added shortly after
the transfections were performed. For the stable experiments, fresh
medium containing IPTG was added daily to the cells.
Flow Cytometry
For the EGFP analysis, transfected cells were harvested, washed,
and resuspended in PBS. Fluorescence data were collected using
a FACSCalibur flow cytometer (BD Biosciences) integrated with Cell-
Quest software. The cells were analyzed with a 488 nm argon excita-
tion laser and a 515–545 nm emission filter (FL1). Data analysis was
performed using WinMDI software, version 2.8 (J. Trotter, The Scripps
Research Institute) and MATLAB (The MathWorks, Inc.). Cell samples
were assayed at a medium flow rate until 30,000 cells had been col-
lected within a forward-scatter and side-scatter gate to minimize fluo-
rescence variation due to cell size.
For the apoptosis study, cells were stained with Alexa Fluor 488-
conjugated annexin V and propidium iodide (PI) using the Vybrant
Apoptosis Assay Kit (Invitrogen) per the manufacturer’s protocol.
Cell samples were assayed at a medium flow rate until 15,000 cells
had been collected.
Fluorescence Microscopy
Coverslips were treated with protamine and placed in the bottoms of
a 12-well plate. Cells were grown on these coverslips overnight and
transfected the next day with 1.6 mg of expression plasmid using
Lipofectamine 2000 reagent (Invitrogen) per the manufacturer’s proto-
col. The following morning, the cells were washed with PBS and fixed
with 4% paraformaldehyde in PBS for 15 min at room temperature.
After fixation, the coverslips were washed with PBS, and mounting
medium was placed on the cells. The coverslips were then mounted
face down onto slides, and the cells were visualized for fluorescence
using a Nikon Eclipse 80i microscope.
Staining for b-Galactosidase
Cells were grown in 12-well plates, and 24 hr after plating, they were
transfected with 0.8 mg of LTRi-cre using Lipofectamine 2000 reagent
(Invitrogen) per the manufacturer’s protocol and exposed to 1 mM
IPTG. Cells were incubated for 48 hr, fixed with paraformaldehyde,
washed with PBS, and stained with X-gal staining buffer.
Staining for Apoptosis and Cell Death
Cells were grown in 12-well plates, and 24 hr after plating, they were
transfected with 0.8 mg of LTRi-bax using Lipofectamine 2000 reagent
(Invitrogen) per the manufacturer’s protocol and exposed to the indi-
cated levels of IPTG. Cells were incubated for 48 hr, and adherent cells
were harvested by mild trypsinization and pooled together with de-
tached cells. Cells were stained with Alexa Fluor 488-conjugated an-
nexin V and PI using the Vybrant Apoptosis Assay Kit (Invitrogen) per
the manufacturer’s protocol. In live cells, phosphatidylserine is
located in the cytoplasmic surface of the cell membrane; however, in
apoptotic cells, it translocates to the outer leaflet of the plasma mem-
brane (van Engeland et al., 1998). Annexin V has a high affinity for
phosphatidylserine; therefore, annexin V conjugated with Alexa Fluor
488 can identify apoptotic cells by binding to phosphatidylserine and
can be analyzed by flow cytometry measuring the fluorescence emis-
sion at 530 nm (FL1). PI accesses the inner cell of dead cells due to
damaged plasma membranes and binds tightly to nucleic acids. It is
impermeable to live and apoptotic cells but stains dead cells with
red fluorescence. Dead cells appear red and can be analyzed by
flow cytometry measuring the red florescence emission >575 nm
(FL3). Moreover, live cells are annexin V negative and PI negative,
apoptotic cells are annexin V positive and PI negative, and dead cells
are annexin V negative and PI positive.
Supplemental Data
Supplemental Data include Supplemental Results, Supplemental
Experimental Procedures, and three figures and can be found with
this article online at http://www.cell.com/cgi/content/full/130/2/363/
DC1/.
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